Prognostic significance of preoperative plasma fibrinogen in endometrial cancer

Gynecologic Oncology

Volumn 119, Issue 2, 2010, Pages 309-313

  Ghezzi, Fabio ^a   Cromi, Antonella ^a   Siesto, Gabriele ^a   Giudici, Silvia ^b   Serati, Maurizio ^a   Formenti, Giorgio ^a   Franchi, Massimo ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Biomarker; Endometrial cancer; Fibrinogen; Metastasis; Prognosis; Survival

Indexed keywords

CISPLATIN; EPIRUBICIN; FIBRINOGEN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; DISEASE FREE SURVIVAL; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN DEFECT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERFIBRINOGENEMIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MULTIPLE CYCLE TREATMENT; MYOMETRIUM; OVERALL SURVIVAL; PELVIS LYMPH NODE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; BLOOD; COHORT ANALYSIS; ENDOMETRIAL NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PREOPERATIVE CARE; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; FIBRINOGEN; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 77957753409     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.07.014     Document Type: Article

References (32)

1. H.F. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing NEJM 315 1986 1650 1659
2. P.J. Simpson-Haidaris, and B. Rybarczyk Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein Ann NY Acad Sci 936 2001 406 425
3. M.W. Mosesson Fibrinogen and fibrin structure and functions J Thromb Haemost 3 2005 1894 1904
4. V. Costantini, L.R. Zacharski, V.A. Memoli, W. Kisiel, B.J. Kudryk, and S.M. Rousseau Fibrinogen deposition without thrombin generation in primary human breast cancer tissue Cancer Res 51 1991 349 353
5. H. Bárdos, P. Molnár, G. Csécsei, and R. Adány Fibrin deposition in primary and metastatic human brain tumours Blood Coagul Fibrinolysis 7 1996 536 548
6. H. Bárdos, A. Juhász, G. Répássy, and R. Adány Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx Thromb Haemost 80 1998 767 772
7. J.S. Palumbo, K.W. Kombrinck, A.F. Drew, T.S. Grimes, J.S. Kiser, and J.L. Degen Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells Blood 96 2000 3302 3309
8. J.S. Palumbo Mechanisms linking tumor cell-associated procoagulant function to tumor dissemination Semin Thromb Hemost 34 2008 154 160
9. K. Blackwell, Z. Haroon, G. Broadwater, D. Berry, L. Harris, and J.D. Iglehart Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status J Clin Oncol 18 2000 600 608
10. H. Yamashita, J. Kitayama, N. Kanno, Y. Yatomi, and H. Nagawa Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer BMC Cancer 6 2006 147
11. J.M. Jones, N.C. McGonigle, M. McAnespie, G.W. Cran, and A.N. Graham Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer Lung Cancer 53 2006 97 101
12. H. Takeuchi, S. Ikeuchi, Y. Kitagawa, A. Shimada, T. Oishi, and Y. Isobe Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus J Gastroenterol Hepatol 22 2007 2222 2227
13. H. Yamashita, J. Kitayama, M. Taguri, and H. Nagawa Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systematic inflammatory response World J Surg 33 2009 1298 1305
14. Q. Guo, B. Zhang, X. Dong, Q. Xie, E. Guo, and H. Huang Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor Pancreas 38 2009 e75 e79
15. S. Polterauer, V. Seebacher, K. Hefler-Frischmuth, C. Grimm, G. Heinze, and C. Tempfer Fibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer Am J Obstet Gynecol 200 2009 647.e1 647.e7
16. Y. Ma, Y. Qian, and W. Lv The correlation between plasma fibrinogen levels and clinical features of patients with ovarian carcinoma J Int Med Res 35 2007 678 684
17. S. Polterauer, C. Grimm, V. Seebacher, N. Concin, C. Marth, and C. Tomovski Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study Oncologist 14 2009 979 985
18. V. Seebacher, S. Polterauer, C. Grimm, H. Husslein, H. Leipold, and K. Hefler-Frischmuth The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial Br J Cancer 102 2010 952 956
19. F. Ghezzi, A. Cromi, V. Bergamini, S. Uccella, P. Beretta, and M. Franchi Laparoscopic-assisted vaginal hysterectomy versus total laparoscopic hysterectomy for the management of endometrial cancer: a randomized clinical trial J Minim Invasive Gynecol 13 2006 114 120
20. F. Ghezzi, A. Cromi, S. Uccella, G. Siesto, S. Giudici, and M. Serati Laparoscopic versus open surgery for endometrial cancer: a minimum 3-year follow-up study Ann Surg Oncol 17 2010 271 278
21. P. Benedetti Panici, S. Basile, and F. Maneschi Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 2008 1707 1716
22. C.S. Roxburgh, and D.C. McMillan Role of systemic inflammatory response in predicting survival in patients with primary operable cancer Future Oncol 2010 149 163
23. K.C. Fearon, M.D. Barber, J.S. Falconer, D.C. McMillan, J.A. Ross, and T. Preston Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia World J Surg 23 1999 584 588
24. M. Schmid, A. Schneitter, S. Hinterberger, J. Seeber, A. Reinthaller, and L. Hefler Association of elevated C-reactive protein levels with an impaired prognosis in patients with surgically treated endometrial cancer Obstet Gynecol 110 2007 1231 1236
25. S.Y. Lee, K.P. Lee, and J.W. Lim Identification and biosynthesis of fibrinogen in human uterine cervix carcinoma cells Thromb Haemost 75 1996 466 470
26. E.P. Molmenti, T. Ziambaras, and D.H. Perlmutter Evidence for an acute phase response in human intestinal epithelial cells J Biol Chem 268 1993 14116 14124
27. G.A. Kalweit, P. Feindt, M. Micek, E. Gams, and P. Hellstern Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood Thromb Res 97 2001 105 111
28. E. Camerer, A.A. Qazi, D.N. Duong, I. Cornelissen, R. Advincula, and S.R. Coughlin Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis Blood 104 2004 397 401
29. ASTEC study group H. Kitchener, A.M. Swart, Q. Qian, C. Amos, and M.K. Parmar Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 2009 125 136
30. Y. Todo, H. Kato, M. Kaneuchi, H. Watari, M. Takeda, and N. Sakuragi Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis Lancet 375 2010 1165 1172
31. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 6 1987 2035 2041
32. A.S. Case, R.P. Rocconi, J.M. Straughn Jr, M. Conner, L. Novak, and W. Wang A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer Obstet Gynecol 108 2006 1375 1379